About: Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2 clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's disease. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.21 (-6.23%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
SAVA NASDAQ Cassava Sciences Inc
Cassava Sciences Inc share price
SAVA price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
SAVA price performance
SAVA Market Signals